金新農(002548.SZ):股東陳俊海、王堅能增持承諾已履行完畢
格隆匯 6 月 29日丨金新農(002548.SZ)公佈,截至2020年6月29日,陳俊海、王堅能已經完成了《股權轉讓合同》中關於增持公司股份的承諾,截至2020年6月29日陳俊海通過證券交易系統集中競價交易方式累計增持公司股份289.141萬股,增持金額為人民幣約2315.9萬元,增持均價約為8.01元/股,增持資金來源為自有資金;王堅能通過證券交易系統集中競價交易方式累計增持公司股份27.25萬股,增持金額為人民幣約216.25萬元,增持均價約為7.94元/股,增持資金來源為自有資金。陳俊海、王堅能的增持承諾已履行完畢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.